Dissecting the genetic basis of kidney tubule response to hyperoxaluria using chromosome substitution strains.
Whether genetics may play a role in the pathophysiologic response of kidney tubules to oxalate exposure remains unexplored despite that as many as 15% of the U.S. population annually will experience a kidney stone composed of calcium oxalate. To explore this issue, we utilized a panel of chromosome substitution strains in which one chromosome at a time was transferred from the Brown Norway (BN) rat onto the Dahl salt-sensitive (SS) genetic background. Hyperoxaluria was induced by adding hydroxyproline (HP) to the drinking water. A dose-response (0-2% HP) study found that both SS and BN exhibited the same level of oxalate excretion as HP concentration increased, but only the BN exhibited changes in urothelial pathology and demonstrated crystal deposition at sites of urothelial injury as a function of dose (at 1.5-2.0%). The consomic panel was treated with 2.0% HP and evaluated for hyperoxaluria, renal injury, and crystal deposition. Tubular injury (% Area) and crystal deposition (% Area) were similar between the resistant SS and SS-4, -6, -7, -8, -9, -11, -16, and -20(BN) consomic rats. However, tubular injury was significantly increased in SS-2(BN) compared with the SS parental (9.8 +/- 1.56 and 4.2 +/- 1.09%, respectively). Crystal deposition was observed in SS-2(BN) and SS-18(BN) (4.7 +/- 0.70 and 3.5 +/- 1.3%, respectively) to the same extent as seen in the susceptible BN (3.2 +/- 0.44%). The fact that crystal deposition was observed in SS-18(BN) without extensive overall tubule injury, compared with the more severe widespread tubular injury seen in SS-2(BN), suggests that the underlying mechanism of each locus is different. In conclusion, these studies establish that BN rats demonstrate oxalate-associated pathology and they retain calcium oxalate crystals coincident with urothelial injury but SS rats do not. These observations establish that BN rat chromosome 2 and 18 harbor genes that contribute to these processes.
Wiessner
John H
JH
Kidney Disease Center, Medical College of Wisconsin and Department of Veterans Affairs Medical Center, Milwaukee, Wisconsin 53295, USA.
Garrett
Michael R
MR
Roman
Richard J
RJ
Mandel
Neil S
NS
D000818:Animals; D020296:Animals, Congenic; D002129:Calcium Oxalate / Q000652:urine; D033481:Chromosomes, Mammalian; D004195:Disease Models, Animal; D020022:Genetic Predisposition to Disease; D006909:Hydroxyproline; D006959:Hyperoxaluria / Q000139:chemically induced / Q000235:genetics* / Q000473:pathology / Q000652:urine; D007669:Kidney Calculi / Q000139:chemically induced / Q000235:genetics* / Q000473:pathology / Q000652:urine; D007684:Kidney Tubules / Q000378:metabolism / Q000473:pathology*; D008297:Male; D010641:Phenotype; D051381:Rats; D011914:Rats, Inbred BN; D020303:Rats, Inbred Dahl; D012720:Severity of Illness Index; D013045:Species Specificity; D013997:Time Factors; D019459:Urothelium / Q000473:pathology
D002129:Calcium Oxalate; D006909:Hydroxyproline